Convalescent plasma can be effective early COVID-19 therapy, study finds

Research shows that high-titer (antibody-rich) COVID convalescent plasma -- when administered to COVID-19 outpatients within nine days after testing positive -- reduced the need for hospitalization for more than half of a study's predominantly unvaccinated outpatients.

from Top Health News -- ScienceDaily https://ift.tt/5q4Yx9F